Perrigo Co's average Accounts Receivable for the
three
months ended in Mar. 2025 was $680 Mil. Perrigo Co's Revenue for the
three
months ended in Mar. 2025 was $1,044 Mil.
Hence, Perrigo Co's Days Sales Outstanding for the
three
months ended in Mar. 2025 was 59.40.
The historical rank and industry rank for Perrigo Co's Days Sales Outstanding or its related term are showing as below:
PRGO'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 54.96 Med: 82.22 Max: 109.23
Current: 61.48
During the past 13 years, Perrigo Co's highest Days Sales Outstanding was 109.23. The lowest was 54.96. And the median was 82.22.
PRGO's Days Sales Outstanding is ranked better than 62.24% of 948
companies
in the Drug Manufacturers industry
Industry Median: 72.635
vs PRGO: 61.48
Perrigo Co's Days Sales Outstanding
declined
from Mar. 2024 (64.07) to Mar. 2025 (59.40).
Perrigo Co Days Sales Outstanding Historical Data
The historical data trend for Perrigo Co's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Perrigo Co's Days Sales Outstanding
For the Drug Manufacturers - Specialty & Generic subindustry, Perrigo Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Perrigo Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Perrigo Co's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Perrigo Co's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Perrigo Co (NYSE:PRGO) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Perrigo Co Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Perrigo Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PRGO has been successfully added to your 